In this study, researchers aimed to determine whether younger BRCA1/2 carriers who undergo oophorectomy can receive menopausal hormone therapy without increasing their risk of breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback